| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Director | Sell | 63,247 | $25.13 | $1,589,194.72 | -50.1% | -15.2% | +6.8% | |
| Jan 9, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,000 | $60.00 | $60,000.00 | -1.2% | +12.1% | +18.3% | |
| Jan 9, 2023 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 2,244 | $37.62 | $84,419.28 | -22.2% | +40.7% | +80.7% | |
| Jan 4, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 3,170 | $0.26 | $832.13 | -3.0% | +28.4% | -67.4% | |
| Jan 4, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 1,630 | $0.26 | $427.88 | -8.3% | +28.4% | -67.4% | |
| Jan 4, 2023 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 292 | $24.05 | $7,022.60 | -0.1% | -45.8% | +32.1% | |
| Jan 3, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $22.90 | $205,138.20 | -1.4% | -2.0% | -8.7% | |
| Jan 3, 2023 | PRPO Precipio, Inc. | Danieli Ilan | Chief Executive Officer | Buy | 16,500 | $0.60 | $9,857.10 | +40.7% | +7.4% | -49.0% | |
| Jan 3, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,704 | $22.89 | $176,316.28 | -1.9% | -2.0% | -8.7% | |
| Jan 3, 2023 | PRPO Precipio, Inc. | Sabet Ahmed Zaki47 | Chief Operating Officer | Buy | 750 | $0.60 | $448.05 | +12.3% | +7.4% | -49.0% | |
| Jan 3, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,818 | $11.69 | $32,935.94 | -1.0% | -21.3% | -1.4% | |
| Jan 3, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 8,212 | $39.55 | $324,805.95 | -8.0% | +41.0% | +53.8% | |
| Jan 3, 2023 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 2,706 | $39.55 | $107,029.88 | -0.4% | +41.0% | +53.8% | |
| Jan 3, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,236 | $39.55 | $48,887.51 | -0.2% | +41.0% | +53.8% | |
| Jan 3, 2023 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 4,856 | $39.55 | $192,067.91 | -44.1% | +41.0% | +53.8% | |
| Jan 3, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,644 | $39.55 | $144,129.67 | -3.6% | +41.0% | +53.8% | |
| Dec 31, 2022 | WGS Genedx Holdings Corp. | Ryan Jason65 | Executive Chairman | Sell | 73,732 | $0.26 | $19,310.41 | -28.0% | +38.4% | -69.7% | |
| Dec 29, 2022 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 7,279 | $40.27 | $293,137.34 | -6.5% | +40.0% | +54.2% | |
| Dec 28, 2022 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 134 | $39.84 | $5,338.91 | - | +35.9% | +55.7% | |
| Dec 28, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 728 | $39.84 | $29,005.41 | -0.5% | +35.9% | +55.7% | |
| Dec 28, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,605 | $39.84 | $103,789.97 | -3.0% | +35.9% | +55.7% | |
| Dec 28, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 915 | $39.84 | $36,455.98 | -1.0% | +35.9% | +55.7% | |
| Dec 27, 2022 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 20,000 | $15.15 | $302,992.00 | -5.1% | +51.7% | +28.7% | |
| Dec 23, 2022 | IMDX Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Director | Buy | 75,000 | $0.33 | $24,727.50 | New | -39.0% | -65.9% | |
| Dec 23, 2022 | IMDX Insight Molecular Diagnostics Inc. | Arno Andrew | Director | Buy | 250,000 | $0.35 | $87,875.00 | +88.6% | -39.0% | -65.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.